Situational factors and patterns associated with smokeless tobacco use
- PMID: 1942016
- DOI: 10.1007/BF00845114
Situational factors and patterns associated with smokeless tobacco use
Abstract
Situational factors and topographic features associated with smokeless tobacco use were examined. Male smokeless tobacco users (N = 30) were asked to record the time, activity, and internal states associated with each dip of tobacco use over the course of 10 days. Additionally, these subjects were asked to record the activity and internal state they were experiencing every hour for a 15-hr waking period to obtain baseline rates of these events. Serum and saliva samples were obtained to measure cotinine concentrations. The activities significantly associated with smokeless tobacco use included after a meal, while driving, and while watching television. The internal states associated with smokeless tobacco use were feeling relaxed and depressed. Factor analysis of the events showed factors which are different from those found among cigarette smokers. Examination of the topographic measures of smokeless tobacco use showed that the total dip duration per day was 283.5 min, with a range of 79.7-757.1 min. This measure, along with duration of dipping time (time from onset to offset of smokeless tobacco use during the day), may be the best predictors of nicotine exposure.
Similar articles
-
Topographical features of smokeless tobacco use.Psychopharmacology (Berl). 1988;96(3):428-9. doi: 10.1007/BF00216076. Psychopharmacology (Berl). 1988. PMID: 3146780
-
Saliva cotinine and thiocyanate: chemical indicators of smokeless tobacco and cigarette use in adolescents.J Behav Med. 1988 Oct;11(5):423-33. doi: 10.1007/BF00844836. J Behav Med. 1988. PMID: 3236378
-
Smokeless tobacco abstinence effects and nicotine gum dose.Psychopharmacology (Berl). 1992;106(1):60-6. doi: 10.1007/BF02253589. Psychopharmacology (Berl). 1992. PMID: 1738794 Clinical Trial.
-
Oral spit tobacco: addiction, prevention and treatment.Nicotine Tob Res. 1999 Mar;1(1):21-44. doi: 10.1080/14622299050011131. Nicotine Tob Res. 1999. PMID: 11072386 Review.
-
Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?Nicotine Tob Res. 2010 Nov;12(11):1055-67. doi: 10.1093/ntr/ntq147. Epub 2010 Sep 16. Nicotine Tob Res. 2010. PMID: 20847148 Review.
Cited by
-
Evidence supporting product standards for carcinogens in smokeless tobacco products.Cancer Prev Res (Phila). 2015 Jan;8(1):20-6. doi: 10.1158/1940-6207.CAPR-14-0250. Epub 2014 Dec 18. Cancer Prev Res (Phila). 2015. PMID: 25524878 Free PMC article.
-
Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16-F10 melanoma growth in a preclinical model.Oncotarget. 2020 Dec 22;11(51):4770-4787. doi: 10.18632/oncotarget.27839. eCollection 2020 Dec 22. Oncotarget. 2020. PMID: 33473260 Free PMC article.
-
Smokeless tobacco use and religiousness.Int J Environ Res Public Health. 2009 Jan;6(1):225-31. doi: 10.3390/ijerph6010225. Epub 2009 Jan 12. Int J Environ Res Public Health. 2009. PMID: 19440279 Free PMC article.